Publications by authors named "H Heystek"

Claim this Profile
I
In vitro oral drug permeation models: the importance of taking physiological and physico-chemical factors into consideration.
Ruan Joubert, Johan Dewald Steyn, Hendrik Jacobus Heystek, Jan Harm Steenekamp, Jan Lourens Du Preez

Expert Opin Drug Deliv· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.
Heleen C Heystek, Anne-Christine Thierry, Patricia Soulard, Corinne Moulon

Int Immunol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-gamma-mediated signaling.
H C Heystek, B den Drijver, M L Kapsenberg, R A W van Lier, E C de Jong

Clin Immunol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.
Pedro L Vieira, Heleen C Heystek, Jan Wormmeester, Eddy A Wierenga, Martien L Kapsenberg

J Immunol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation.
Heleen C Heystek, Corinne Moulon, Andrea M Woltman, Pierre Garonne, Cees van Kooten

J Immunol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis